Daily Tokens
November 12, 2026

AI · November 12, 2026 · Moderate impact

DeepMind releases AlphaGenome 2 for cell-type-level variant analysis

Google DeepMind unveiled AlphaGenome 2, a model that predicts the effects of genetic variants for individual cell types rather than across bulk tissue. It was trained on more than 107 million cell profiles and identifies nearly twice as many disease-relevant gene changes as its predecessor. The model is available for noncommercial research through an API and is set to be integrated into Google's agentic platform Antigravity.

Researchers get a more granular tool for linking DNA variants to specific cell types and disease, available now for noncommercial work.

Go deeper

More from AI on Thursday, November 12